Panacea Life Sciences Holdings Inc
Panacea Life Sciences Holdings, Inc., operates as a holding company, researchers, develops, manufactures, produces, and distributes cannabinoids, mushrooms, kratom, and other natural, plant-based ingredients and products for humans and animals. It provides a range of products, including Nitro Kava, Kratom, hemp, VAPE products, and various beverages that focuses on promoting alternative health and… Read more
Panacea Life Sciences Holdings Inc (PLSH) - Total Liabilities
Latest total liabilities as of September 2025: $234.03K USD
Based on the latest financial reports, Panacea Life Sciences Holdings Inc (PLSH) has total liabilities worth $234.03K USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Panacea Life Sciences Holdings Inc - Total Liabilities Trend (2017–2023)
This chart illustrates how Panacea Life Sciences Holdings Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Panacea Life Sciences Holdings Inc Competitors by Total Liabilities
The table below lists competitors of Panacea Life Sciences Holdings Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
InnoCan Pharma Corporation
OTCQB:INNPF
|
USA | $4.49 Million |
|
TYSON FOODS -A- - Dusseldorf Stock Exchang
DU:TF7A
|
Germany | €19.53 Billion |
|
Sentoria Group Bhd
KLSE:5213
|
Malaysia | RM452.47 Million |
|
Ralco Agencies Ltd
TA:RLCO
|
Israel | ILA97.83 Million |
|
Embraer S.A. Reg. Shs
STU:EMY
|
Germany | €7.76 Billion |
|
Energy and Water Development Corp
OTCQB:EAWD
|
USA | $2.99 Million |
|
Infrax Systems Inc
PINK:IFXY
|
USA | $2.48 Million |
|
CAT Strategic Metals Corporation
PINK:CATTF
|
USA | $1.54 Million |
Liability Composition Analysis (2017–2023)
This chart breaks down Panacea Life Sciences Holdings Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 15.75 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.06 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.06 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Panacea Life Sciences Holdings Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Panacea Life Sciences Holdings Inc (2017–2023)
The table below shows the annual total liabilities of Panacea Life Sciences Holdings Inc from 2017 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | $26.27 Million | +21.45% |
| 2022-12-31 | $21.63 Million | +29.69% |
| 2021-12-31 | $16.68 Million | +226.44% |
| 2020-12-31 | $5.11 Million | -16.47% |
| 2019-12-31 | $6.12 Million | +77.89% |
| 2018-12-31 | $3.44 Million | +43.98% |
| 2017-12-31 | $2.39 Million | -- |